Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MPI | P34949 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.31 |
| ▸ | PDE4A | P27815 | 1/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5972505 | 1.00 | MPI (0.46) | MPILMNAL3MBTL1TDP1AKR1B1 | |
| SCHEMBL1922060 | 1.00 | MPI (0.46) | MPILMNAL3MBTL1TDP1AKR1B1 | |
| SCHEMBL18409552 | 0.94 | AKR1B1 (0.44) | MPILMNAL3MBTL1AKR1B1 | |
| SCHEMBL11790470 | 0.89 | MPI (0.48) | MPIAKR1B1PTPN1 | |
| SCHEMBL7152900 | 0.89 | MPI (0.48) | MPIAKR1B1PTPN1 | |
| SCHEMBL3235190 | 0.89 | MPI (0.48) | MPIAKR1B1PTPN1 | |
| SCHEMBL4601534 | 0.86 | MPI (0.46) | MPILMNAL3MBTL1AKR1B1PTPN1 | |
| SCHEMBL7148553 | 0.86 | MPI (0.46) | MPILMNAL3MBTL1AKR1B1PTPN1 | |
| SCHEMBL9738506 | 0.84 | MPI (0.37) | MPILMNAL3MBTL1TDP1AKR1B1 | |
| SCHEMBL3687100 | 0.84 | MPI (0.37) | MPILMNAL3MBTL1TDP1AKR1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2516641-A1 | METHOD FOR THE PRODUCTION OF VERY LONG CHAIN FATTY ACIDS (VLCFA) BY FERMENTATION WITH A RECOMBINANT YARROWIA SP | Institut National De La Recherche Agronomique (FR) | 2012-10-31 | — | — | EP | claimed |
| US-20120226059-A1 | Method for the Production of Very Long Chain Fatty Acids (VLCFA) by Fermentation with a Recombinant Yarrowia SP | INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (FR) | 2012-09-06 | — | — | US | claimed |
| WO-2011064393-A1 | METHOD FOR THE PRODUCTION OF VERY LONG CHAIN FATTY ACIDS (VLCFA) BY FERMENTATION WITH A RECOMBINANT YARROWIA SP | INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (FR) | 2011-06-03 | — | — | WO | claimed |
| EP-2327776-A1 | Method for the production of Very Long Chain Fatty Acids (VLCFA) by fermentation with a recombinant Yarrowia sp | INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (FR) | 2011-06-01 | — | — | EP | claimed |
| US-20260117265-A1 | ELECTRO-BIODIESEL EMPOWERED BY CO-DESIGN OF MICROORGANISM AND ELECTROCATALYSIS | TEXAS A & M UNIV SYS (US) | 2026-04-30 | — | — | US | disclosed |
| EP-4627351-A1 | METHODS FOR DETECTING METABOLIC MARKERS | Cedars-Sinai Medical Center (US) | 2025-10-08 | — | — | EP | disclosed |
| US-20250283891-A1 | METHODS FOR DETECTING METABOLIC MARKERS | CEDARS SINAI MEDICAL CENTER (US) | 2025-09-11 | — | — | US | disclosed |
| EP-4608390-A1 | TUMOUR SENSITISATION TO CHECKPOINT INHIBITORS WITH REDOX STATUS MODIFIER | Cancer Research Technology Limited (GB) | 2025-09-03 | — | — | EP | disclosed |
| EP-4608995-A1 | TUMOUR STRATIFICATION FOR RESPONSIVENESS TO AN IMMUNE CHECKPOINT INHIBITOR | Memorial Sloan-Kettering Cancer Center (US) | 2025-09-03 | — | — | EP | disclosed |
| WO-2024118850-A1 | METHODS FOR DETECTING METABOLIC MARKERS | CEDARS-SINAI MEDICAL CENTER (US) | 2024-06-06 | — | — | WO | disclosed |
| WO-2024089417-A1 | TUMOUR STRATIFICATION FOR RESPONSIVENESS TO AN IMMUNE CHECKPOINT INHIBITOR | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2024-05-02 | — | — | WO | disclosed |
| WO-2024089418-A1 | TUMOUR SENSITISATION TO CHECKPOINT INHIBITORS WITH REDOX STATUS MODIFIER | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2024-05-02 | — | — | WO | disclosed |
| WO-1998046798-A9 | ENHANCED REVERSE TRANSCRIPTASE POLYMERASE CHAIN ASSAY TO DETECT MN IN PATIENTS WITH RENAL CELL CARCINOMA | — | 1999-03-18 | — | — | WO | disclosed |
| WO-1998046798-A1 | ENHANCED REVERSE TRANSCRIPTASE POLYMERASE CHAIN ASSAY TO DETECT MN IN PATIENTS WITH RENAL CELL CARCINOMA | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 1998-10-22 | — | — | WO | disclosed |
| EP-0829104-A1 | HIGH ENERGY DENSITY VANADIUM ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND ALL-VANADIUM REDOX CELLS AND BATTERIES CONTAINING HIGH ENERGY VANADIUM ELECTROLYTE SOLUTIONS | UNISEARCH LIMITED (AU) | 1998-03-18 | — | — | EP | disclosed |
| EP-0729648-A4 | STABILISED ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND REDOX CELLS AND BATTERIES CONTAINING STABILISED ELECTROLYTE SOLUTIONS | UNISEARCH LTD (AU) | 1997-01-02 | — | — | EP | disclosed |
| WO-1996035239-A1 | HIGH ENERGY DENSITY VANADIUM ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND ALL-VANADIUM REDOX CELLS AND BATTERIES CONTAINING HIGH ENERGY VANADIUM ELECTROLYTE SOLUTIONS | UNISEARCH LIMITED (AU) | 1996-11-07 | — | — | WO | disclosed |
| EP-0729648-A1 | STABILISED ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND REDOX CELLS AND BATTERIES CONTAINING STABILISED ELECTROLYTE SOLUTIONS | UNISEARCH LIMITED (AU) | 1996-09-04 | — | — | EP | disclosed |
| WO-1995012219-A1 | STABILISED ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND REDOX CELLS AND BATTERIES CONTAINING STABILISED ELECTROLYTE SOLUTIONS | UNISEARCH LIMITED (AU) | 1995-05-04 | — | — | WO | disclosed |
| US-4112070-A | Blood preservation system | RESEARCH CORPORATION (US) | 1978-09-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260117265-A1 | ELECTRO-BIODIESEL EMPOWERED BY CO-DESIGN OF MICROORGANISM AND ELECTROCATALYSIS | DGAT2, DGAT1, ACSL1 | MPI 996/4885LMNA 3528/4885L3MBTL1 724/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.